Every Form 4 that Intellicheck, Inc. (IDN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IDN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IDN filings page.
Intellicheck, Inc. director David E. Ullman received 5,459 restricted stock units on October 8, 2026. The units convert into common stock on a one-for-one basis and vested in full on the grant date. The transaction also lists a reported per-share amount of $2.29. Ullman directly held 62,556 shares following the transaction.
Intellicheck, Inc. director Guy L. Smith acquired 13,100 restricted stock units on October 8, 2026. The units vested in full on the grant date and convert into common stock one-for-one. Smith’s reported direct common-stock holdings following the transaction were 444,259 shares. The reported transaction price was $2.29 per share.
Intellicheck, Inc. director Dylan Glenn received a grant of 5,459 restricted stock units on October 8, 2026. The units vested in full on the grant date and convert into common stock on a one-for-one basis. The transaction entry lists $2.29 per share; Glenn directly held 97,372 shares following the award.
Intellicheck, Inc. (IDN) director Dondi Black reported acquiring 2,183 restricted stock units on October 8, 2026. The units vested in full on the grant date and convert into common stock on a one-for-one basis. The reported transaction price was $2.29 per share; Black's reported direct holdings after the award were 26,918 shares.
Intellicheck, Inc. director David E. Ullman reported an acquisition of 3,149 shares of common stock on July 15, 2026, via a grant of restricted stock units that convert one-for-one into common shares and vested in full on the Grant Date, bringing his direct holdings to 57,097 shares.
Intellicheck, Inc. director Guy L. Smith received a grant of 7,557 restricted stock units on July 15, 2026 at a reference value of $3.97 per share. The units convert to common stock on a one-for-one basis and vested in full on the grant date, bringing his direct holdings to 431,159 shares. The award was not made under a Rule 10b5-1 trading plan.
Intellicheck, Inc. director Glenn Dylan received a grant of 3,149 restricted stock units on July 15, 2026. These units convert into Common Stock, $.001 par value, on a one-for-one basis and vested in full on the Grant Date.
After this equity award, Dylan directly owns 91,913 shares of Intellicheck common stock. The award is reported at $3.97 per share for Form 4 reporting purposes.
Intellicheck, Inc. director Dondi Black reported an equity compensation grant on July 15, 2026. The filing shows an acquisition of 1,259 shares of common stock at $3.97 per share, representing restricted stock units that vested in full on the grant date, increasing Black’s direct holdings to 24,735 shares.
Intellicheck, Inc. Chief Technology Officer Jonathan Robins reported an open-market sale of company stock. On June 15, 2026, he sold 5,550 shares of Intellicheck common stock at an average price of $4.22 per share.
After this transaction, the filing shows Robins directly owning 0 shares of Intellicheck common stock, and it reports no remaining derivative securities such as options or warrants.
Intellicheck, Inc. director and CEO/President Lewis Bryan reported an indirect disposition of shares through a family trust. On May 1, 2026, The Lewis Family Revocable Living Trust made a bona fide gift transfer of 6,270 shares of Intellicheck common stock at no stated price. Following the gift, the trust continued to hold 33,730 shares indirectly. Mr. Lewis disclaims beneficial ownership of the trust’s shares except to the extent of any pecuniary interest.
Intellicheck, Inc. director and CEO/President Lewis Bryan reported an open-market sale of 10,000 shares of common stock at a weighted average price of $8.0536 per share. The shares are held by The Lewis Family Revocable Living Trust, which now holds 40,000 shares after the transaction.
The trust’s sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 17, 2025, with a selling window from April 6, 2026 to July 31, 2026. Mr. Lewis disclaims beneficial ownership of these shares except to the extent of any pecuniary interest.
Intellicheck, Inc. reported an insider-related sale of common stock by a family trust associated with its CEO and President, Lewis Bryan. On this Form 4, The Lewis Family Revocable Living Trust sold 10,000 shares of Intellicheck common stock at a weighted average price of $8.5145 per share in an open-market transaction.
The filing states that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the trust, with a selling window running from April 6, 2026 to July 31, 2026. After this transaction, the trust continues to hold 50,000 Intellicheck shares indirectly attributed to Mr. Lewis, who disclaims beneficial ownership beyond any pecuniary interest.
Intellicheck, Inc. insider reporting shows The Lewis Family Revocable Living Trust completed an open-market sale of 10,000 shares of Intellicheck common stock at an average price of $7.9503 per share. Following this planned transaction, the trust continues to hold 60,000 Intellicheck shares indirectly attributable to CEO and President Lewis Bryan.
The footnote explains that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the trust, with a specified selling window from April 6, 2026 through July 31, 2026. Mr. Lewis disclaims beneficial ownership of these trust-held shares except to the extent of any pecuniary interest.
Intellicheck, Inc. director and CEO Bryan Lewis reported a gift and a related trust sale of company stock. He made a bona fide gift of 80,000 shares of common stock to The Lewis Family Revocable Living Trust. After this gift, he directly holds 327,126 shares.
The Lewis Family Revocable Living Trust then sold 10,000 shares of Intellicheck common stock at an average price of $7.5254 per share, leaving the trust with 70,000 shares. The trust’s sale was executed under a pre-arranged Rule 10b5-1 trading plan. Mr. Lewis disclaims beneficial ownership of the shares held by the trust.
Intellicheck, Inc. director Dondi Black received an equity grant of 715 restricted stock units that vested immediately and converted into common shares. The units were granted on March 31, 2026 at a reference price of $6.99 per share. Following this grant, Black directly holds 23,476 shares of Intellicheck common stock. This was a compensation-related award, not an open-market purchase.
Intellicheck, Inc. director Gregory Braca received 3,577 restricted stock units on March 31, 2026. The units convert to common stock on a one-for-one basis and vested in full on the grant date. Following this equity award, Braca directly holds 8,325 shares of Intellicheck common stock.
Intellicheck, Inc. director Glenn Dylan received an award of 3,577 restricted stock units on March 31, 2026. The units convert into Common Stock on a one-for-one basis and vested in full on the grant date, effectively giving him 3,577 additional shares. Following this compensation-related award, his directly held Common Stock position increased to 88,764 shares.
Intellicheck, Inc. director Guy L. Smith received an equity award of 4,292 shares of common stock through restricted stock units. The units were granted on March 31, 2026 and converted into common shares on a one-for-one basis, vesting in full on the grant date. Following this grant, Smith directly holds 423,602 shares of Intellicheck common stock. This is a compensation-related award rather than an open-market purchase.
Intellicheck, Inc. Chief Financial Officer Adam Sragovicz received a grant of stock options as part of his compensation. He was awarded options covering 100,351 shares of Common Stock at an exercise price of $5.6000 per share, with no cash paid at grant.
All 100,351 options were newly granted and represent his entire reported option position after this transaction. According to the vesting terms, one-third of the options will vest on the first anniversary of the grant date, and the remaining two-thirds will vest quarterly over the following two years, aligning his incentives with longer-term company performance.
Intellicheck, Inc. Chief Technology Officer Jonathan Robins received a grant of stock options covering 77,000 shares of common stock. The options have an exercise price of $5.6000 per share and relate to common stock with $.001 par value.
According to the terms, one-third of the option vests on the first anniversary of the grant date, with the remaining two-thirds vesting quarterly over the following two years. The options expire on 2033-03-24, and Robins’ reported holdings after this grant are 77,000 derivative securities, held directly.
This grant is compensation-related and does not represent an open-market purchase or sale of Intellicheck shares.
Intellicheck, Inc. reported that CEO and President Lewis Bryan received a grant of 146,300 stock options with an exercise price of $5.60 per share. One-third of the option vests on the first anniversary of the grant date, with the remaining two-thirds vesting quarterly over the following two years, and the option expires on March 24, 2033. Following this grant, Bryan holds 146,300 options directly, reflecting a compensation award rather than an open-market trade.
Intellicheck, Inc. director Gregory Braca reported an equity compensation transaction. On January 5, 2026, he was credited with 3,925 Restricted Stock Units (RSUs) at a price of $0.00 per unit, leaving him with 3,925 derivative securities beneficially owned directly after the transaction. According to the footnote, these RSUs became earned and vested on January 5, 2026, and shares of common stock were issued in settlement of the vested RSUs.
Intellicheck director Guy L. Smith reported an equity award in the form of derivative securities. On January 5, 2026, he acquired 4,710 Restricted Stock Units (RSUs), shown with a conversion or exercise price of $6.37 per unit and a price of $0 for the derivative security itself. A footnote explains that these RSUs became earned and vested on that date and that shares of common stock were issued in settlement of the vested RSUs. Following the transaction, the filing shows 4,710 derivative securities beneficially owned directly.
Intellicheck, Inc. director Glenn Dylan reported an equity award in a Form 4. On January 5, 2026, he acquired 2,355 restricted stock units (RSUs) at a price of $0.00 per unit. According to the footnote, these RSUs became earned and vested on that date, and an equal number of shares of common stock were issued in settlement. Following this transaction, Dylan beneficially owns 2,355 derivative securities directly, reflecting this RSU grant and vesting into common shares.
Intellicheck, Inc. director Dondi Black reported the vesting of restricted stock units. On January 5, 2026, 785 Restricted Stock Units (RSUs) became earned and vested, with shares of common stock issued in settlement of these vested RSUs. The Form 4 shows these RSUs as acquired at a price of $0 per unit. Following this transaction, Black beneficially owns 785 derivative securities directly, reflecting the vested RSU position with Intellicheck.
Intellicheck, Inc. director David E. Ullman reported an equity award in the form of restricted stock units. On January 5, 2026, 1,962 Restricted Stock Units became earned and vested, and the same number of shares of common stock were issued in settlement of these vested units. Following this transaction, Ullman beneficially owns 1,962 derivative securities directly related to Intellicheck common stock.
Intellicheck, Inc. (IDN) director share purchase reported. A director acquired 1,000 shares of Intellicheck common stock on 11/25/2025 at a price of $6.18 per share. Following this open-market purchase, the director directly holds 392,948 shares of Intellicheck common stock. The filing was made on a Form 4, which discloses changes in insider ownership.